We are live on
!
Find out more
SCM
Stellar Capital Management Portfolio holdings
AUM
$147M
1-Year Est. Return
5.91%
This Fund
S&P 500
This Quarter
Est. Return
-0.88%
1 Year Est. Return
+5.91%
3 Year Est. Return
+23.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
+$10.1M
(+11%)
Cap. Flow
+$11.7M
Cap. Flow
% of AUM
11.38%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
68
New
4
Increased
52
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.25M |
| 2 |
Chevron
CVX
|
+$898K |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$648K |
| 4 |
PepsiCo
PEP
|
+$520K |
| 5 |
ExxonMobil
XOM
|
+$492K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$793K |
| 2 |
UGI
UGI
|
+$203K |
| 3 |
IBM
IBM
|
+$35.8K |
| 4 |
ResMed
RMD
|
+$32.5K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$10.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.83% |
| 2 | Healthcare | 13.98% |
| 3 | Industrials | 12.78% |
| 4 | Energy | 8.46% |
| 5 | Financials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $436K | 0.42% |
39,103
+3,692
| +10% | +$41.7K |
|
52
Pfizer
PFE
$144B
| $425K | 0.41% |
12,867
| – | – |
|
53
McDonald's
MCD
$194B
| $377K | 0.37% |
3,868
+150
| +4% | +$14.2K |
|
|
54
Edwards Lifesciences
EW
$48.2B
| $358K | 0.35% |
15,090
-35,340
| -70% | -$793K |
|
55
Honeywell
HON
$78.3B
| $315K | 0.31% |
3,361
| – | – |
|
|
56
ResMed
RMD
$30.3B
| $270K | 0.26% |
3,760
-500
| -12% | -$32.5K |
|
|
57
IBM
IBM
$214B
| $256K | 0.25% |
1,670
-236
| -12% | -$35.8K |
|
58
Automatic Data Processing
ADP
$106B
| $250K | 0.24% |
2,925
+450
| +18% | +$38.8K |
|
59
Stratasys
SSYS
$690M
| $245K | 0.24% |
4,635
+875
| +23% | +$58K |
|
60
CSX Corp
CSX
$94.2B
| $223K | 0.22% |
+20,232
| New | +$233K |
|
61
Clorox
CLX
$12.1B
| $217K | 0.21% |
1,965
| – | – |
|
62
Verizon
VZ
$201B
| $211K | 0.21% |
+4,329
| New | +$209K |
|
|
63
Vanguard FTSE Developed Markets ETF
VEA
$225B
| $208K | 0.2% |
5,231
-270
| -5% | -$10.6K |
|
64
ConocoPhillips
COP
$139B
| $202K | 0.2% |
3,240
+102
| +3% | +$6.59K |
|
|
MMT
65
Aberdeen Multi-Market Income Fund
MMT
$238M
| $98K | 0.1% |
15,425
+2,725
| +21% | +$17.3K |
|
|
66
UGI
UGI
$7.92B
| – | – |
-5,364
| Closed | -$203K |
|
Similar funds
JT
BC
LI
SC
BWM
CCM
CCM
LM
Stellar Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Stellar Capital Management held 68 positions worth $103M, up 11% from $92.8M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Stellar Capital Management deployed $11.7M of net new capital in Q1 2015, opening 4 new positions and adding to 52 existing holdings. Its largest new stake was Gilead Sciences: 12,322 shares worth $1.21M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $793K trimmed.
- Stellar Capital Management's largest Q1 2015 buy was Gilead Sciences: 12,322 shares worth $1.21M.
- Stellar Capital Management added most to Chevron in Q1 2015, an estimated $898K increase.
- Stellar Capital Management's biggest Q1 2015 reduction was Edwards Lifesciences, cutting an estimated $793K.
- Stellar Capital Management fully exited UGI in Q1 2015, selling an estimated $203K.
- Stellar Capital Management's ten largest holdings make up 32% of its $103M portfolio in Q1 2015.
- Stellar Capital Management opened 4 new positions and closed 1 in Q1 2015.
- Stellar Capital Management's portfolio value rose 11% quarter-over-quarter to $103M.
Based on Stellar Capital Management's 13F filing for Q1 2015, filed 27 Apr 2015.